Clinical trial
A Randomised, Placebo-controlled Pilot Trial to Examine the Efficacy of Interventions to Prevent Left Ventricular Remodelling in Patients Receiving New Pacemaker Implantation (OPT-Prevent-pilot).
NCT03422705 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Placebo-controlled Pilot Trial to Examine the Efficacy of Interventions to Prevent Left Ventricular Remodelling in Patients Receiving New Pacemaker Implantation (OPT-Prevent-pilot).
- Lead sponsor
- University of Leeds
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 1, 2022
- Completion date
- December 1, 2022
- Enrollment
- 75 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pacemakers, heart failure